China Dedicated RMB 3.5 Billion For TCM Development In 2008
This article was originally published in PharmAsia News
Executive Summary
China's National Development and Reform Commission, Ministry of Finance and Ministry of Science and Technology allocated funds of more than RMB 3.5 billion ($512.36 million) in 2008 to support traditional Chinese medicine development. The unprecedented financial support in terms of strength and scope covers health care, education, research, culture and infrastructure establishment of TCM hospitals. Of the amount, RMB 31 million ($4.53 million) came from central finance for an innovative program to publicize and popularize TCM knowledge nationwide. Recently, NDRC and the State Administration of Traditional Chinese Medicine jointly identified 16 key TCM clinical research areas for development. With investment of more than RMB 4 billion ($585 million), the project is scheduled to begin in 2009. The increased funding seeks to accelerate changes in TCM fundamentals and innovation. (Click here for more - Chinese Language)
You may also be interested in...
China’s 2008 Top 10 TCM News
China's State Administration of Traditional Chinese Medicine has picked the top 10 TCM news events of 2008
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.